Publications
Specialty
Search
IO Learning
06/20/2024
In this episode of the SIO Corner podcast, Katerina Lee, MD, discusses her study regarding the use of a smartphone augmented reality guidance system for composite ablation margins in phantom models.
The Dermatologist
06/20/2024
Atopic dermatitis (AD) significantly impacts adults, with a meta-analysis showing that 26.1% of AD cases have an onset after age 16 years.
Rheumatology & Arthritis
06/20/2024
Drs Majithia and Butendieck provide some perspective on the continuing issues surrounding the diagnosis and effective treatment of gout, the most common inflammatory arthritis in the US.
Neurology, Psych Congress Network
06/19/2024
Lecanemab, a recently FDA-approved treatment for Alzheimer disease (AD) may have a low eligibility rate (6.2%) among patients aged 70-89 years, according to recent results published in the journal Neurology.
Wounds
06/19/2024
The second June Wound Care Wednesday episode continues the conversation of cellular, acellular, and matrix products to heal wounds. Because June is Men's Health Awareness Month, host Dr Jonathan Johnson and guest Dr Naz Wahab discuss the impact of ischemic disorders on skin diseases and wound healing in men, with tips on how men can improve their health.
First Report Managed Care
06/19/2024
A study evaluated the efficacy, safety, pharmacokinetics, and pharmacodynamics of emicizumab in infants from birth to age ≤12 months who have hemophilia A without factor VIII inhibitors.
Cath Lab Digest, CardioVascular
06/19/2024
Drs Kern and Rizik talk with Dr. Jennifer Rymer, who published a study on cath lab procedure volumes and outcomes among early-career interventional cardiologists, and Dr. Pinak Shah, who wrote an accompanying editorial, "Is There an Experience/Exposure Paradox in Interventional Cardiology?"
Wound Care
06/19/2024
A 13-patient randomized, controlled, open-label pilot study comparing Debritom+ with sharp debridement was published. The results may indicate a modestly faster reduction in wound area with Debritom+ and provide feasibility for a sufficiently powered multi-center trial. JWC
Wound Care
06/19/2024
An article, “A review of the proposed draft CAMPs LCDs compared to evidence-based medicine: a letter to the MACs for consideration,” considers Medicare RWE data in the number of CAMP applications, medical necessity, and treatment of non-DFUs and VLUs. JWC
Wound Care
06/19/2024
A 272-patient RCT will examine the efficacy of multiple human placental-based skin substitutes and SoC vs SoC alone for treatment of DFUs with primary outcome of percentage of wounds with complete closure at 12 weeks. Not yet recruiting; the estimated completion is June 2026. clinicaltrials.gov
Wound Care
06/19/2024
MIMOSA, a Canadian diagnostics company, announced the successful closing of its latest round of financing, which was intended to fuel the company’s ongoing commercial expansion and organizational growth.
Wound Care
06/19/2024
SolasCure has been chosen for Innovate UK’s Global Incubator Program. This 6-month program, which is fully funded and delivered in partnership with the Texas Medical Centre, focuses on commercializing innovative solutions for unmet healthcare needs.
Wound Care
06/19/2024
A 150-patient multi-center RCT will examine the effect of Derm-Maxx ADM on the healing rate of chronic DFUs unresponsive to SoC with primary outcome of the rate of wound closure at 12 weeks. The estimated study completion is Sept 2025. clinicaltrials.gov
Pharmacy Learning Network
06/19/2024
Pacira Pharmaceuticals Inc. is recalling 43 768 kits of Zilretta (triamcinolone acetonide extended-release injectable suspension) for failing stability testing.
Wound Care
06/19/2024
A nationwide study of factors predicting burn readmissions (2016-2018) in 41,500 older adult patients found the 90-day readmission rate was 25.6% with 96.5% unplanned. An increased hospital frailty risk and lower-body-only burns were leading factors for readmissions. BCR
Pharmacy Learning Network
06/19/2024
Imprimis NJOF is recalling 136,005 units of Klarity-C Drops (cyclosporine 0.1%) preservative-free ophthalmic emulsion for topical use because of sterility concerns.
Pharmacy Learning Network
06/19/2024
A lack of assurance of sterility has prompted Imprimis NJOF to voluntarily recall 4280 boxes of compounded prednisolone acetate 1%, moxifloxacin 0.5%, and bromfenac 0.075% ophthalmic suspension.
Oncology
06/19/2024
Martijn Meijerink, MD, PhD, shares results from the COLLISION trial which compared thermal ablation to surgical resection for patients with smaller colorectal liver metastases.
Wound Care
06/19/2024
A 20-patient RCT was completed for the use of AMNIODERM+ amniotic membrane for the treatment of non-healing wounds with primary outcome of number of wounds healed at 6 and 12 weeks. The results of the study have not been published. clinicaltrials.gov
Gastroenterology
06/19/2024
In this episode of Gut Check, host Brian Lacy, MD, talks with Dr Ami Sperber about how disorders of gut-brain interaction can overlap, and how this can change treatment paradigms.